Anti-SS-B
- UID
- IMP/IVD/2021/000558_daf5771383446641e99729d74fa6422d_f398ff5b98a2babd37b84ed378307b78
- Device class
- Class B
- Brand name
- Anti-Gliadin IgG
- License holder
- Sebia Diagnostics India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Anti-SS-B is an ELISA-based test system for the quantitative measurement of IgG class autoantibodies against SS-B in human serum or plasma samples. This product is intended for professional in vitro diagnostic use only. Antibodies against SS-B are used for the differential diagnosis of systemic inflammatory autoimmune diseases. Autoantibodies against the SS-B protein are usually found together with anti-SS-A in cases of Sjoegren’s syndrome. Evaluation of a test result should always take into account all clinical and laboratory diagnostic findings
Anti-SS-B is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000558_daf5771383446641e99729d74fa6422d_f398ff5b98a2babd37b84ed378307b78. This device is marketed under the brand name Anti-Gliadin IgG. The license holder is Sebia Diagnostics India Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.